In vivo imaging of tumors with protease-activated near-infrared fluorescent probes (original) (raw)

References

  1. Devita, V., Hellman, S. & Rosenberg, S. Cancer: Principles and Practice of Oncology (Lippincott, Philadelphia, PA, 1997).
    Google Scholar
  2. Stocchi, L. & Nelson, H. Diagnostic and therapeutic applications of monoclonal antibodies in colorectal cancer. Dis. Colon. Rectum. 41, 232–250 ( 1998).
    Article CAS Google Scholar
  3. Kopans, D.B. Updated results of the trials of screening mammography. Surg. Oncol. Clin. N. Am. 6, 233–263 (1997).
    Article CAS Google Scholar
  4. Baum, R.P. & Brummendorf, T.H. Radioimmunolocalization of primary and metastatic breast cancer. Q. J. Nucl. Med. 42, 33–42 (1998).
    CAS PubMed Google Scholar
  5. Teates, C.D. & Parekh, J.S. New radiopharmaceuticals and new applications in medicine. Curr. Probl. Diagn. Radiol. 22, 229–266 (1993).
    Article CAS Google Scholar
  6. Dessureault, S. et al. Pre-operative assessment of axillary lymph node status in patients with breast adenocarcinoma using intravenous 99mtechnetium mAb-170H.82. Breast Cancer Res. Treat. 45, 29–37 (1997).
    Article CAS Google Scholar
  7. Pasqualini, R., Koivunen, E. & Ruoslahti, E. Alpha v integrins as receptors for tumor targeting by circulating ligands. Nat. Biotechnol. 15, 542–546 (1997).
    Article CAS Google Scholar
  8. Neri, D. et al. Targeting by affinity-matured recombinant antibody fragments on an angiogenesis associated fibronectin isoform. Nat. Biotechnol. 15 , 1271–1275 (1997).
    Article CAS Google Scholar
  9. Buchsbaum, D.J. Experimental tumor targeting with radiolabeled ligands. Cancer 80, 2371–2377 ( 1997).
    Article CAS Google Scholar
  10. Rusckowski, M., Qu, T., Chang, F. & Hnatowich, D.J. Technetium-99m labeled epidermal growth factor-tumor imaging in mice. J. Pept. Res. 50, 393–401 ( 1997).
    Article CAS Google Scholar
  11. Goodwin, D.A. & Meares, C.F. Pretargeting: general principles: October 10-12, 1996. Cancer 80, 2675– 2680 (1997).
    Article CAS Google Scholar
  12. Jain, R. Delivery of molecular medicine to solid tumors. Science 271, 1079–1080 (1996).
    Article CAS Google Scholar
  13. Muldoon, L.L. et al. Comparison of intracerebral inoculation and osmotic blood-brain barrier disruption for delivery of adenovirus, herpesvirus, and iron oxide particles to normal rat brain. Am. J. Pathol. 147, 1840–1851 (1995).
    CAS PubMed PubMed Central Google Scholar
  14. Roselli, M. et al. Systemic administration of recombinant interferon alfa in carcinoma patients upregulates the expression of the carcinoma-associated antigens tumor-associated glycoprotein-72 and carcinoembryonic antigen. J. Clin. Oncol. 14, 2031–2042 (1996).
    Article CAS Google Scholar
  15. Leto, G., Gebbia, N., Rausa, L. & Tumminello, F. Cathepsin D in the malignant progression of neoplastic diseases. Anticancer Res. 12, 235–240 ( 1992).
    CAS PubMed Google Scholar
  16. Keppler, D. et al. Tumor progression and angiogenesis: cathepsin B & Co. Biochem. Cell. Biol. 74, 799–810 (1996).
    Article CAS Google Scholar
  17. Kim, J., Yu, W., Kovalski, K. & Ossowski, L. Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay. Cell 94, 353– 362 (1998).
    Article CAS Google Scholar
  18. Callahan, R., Bogdanov, A., Fischman, A., Brady, T. & Weissleder, R. Preclinical evaluation and phase I clinical trial of a 99mTc labeled synthetic polymer used in blood pool imaging. AJR 171, 137–143 (1998).
    Article CAS Google Scholar
  19. Marecos, E., Weissleder, R. & Bogdanov, A., Jr. Antibody-mediated versus nontargeted delivery in a human small cell lung carcinoma model. Bioconjugate Chemistry 9, 184–191 ( 1998).
    Article CAS Google Scholar
  20. Quintart, J., Leroy-Houyet, M.A., Trouet, A. & Baudhuin, P. Endocytosis and chloroquine accumulation during the cell cycle of hepatoma cells in culture. J. Cell Biol. 82, 644– 653 (1979).
    Article CAS Google Scholar
  21. Liaudet, E., Derocq, D., Rochefort, H. & Garcia, M. Transfected cathepsin D stimulates high density cancer cell growth by inactivating secreted growth inhibitors. Cell Growth Differ. 6, 1045–1052 (1995).
    CAS PubMed Google Scholar
  22. Garcia, M. et al. Biological and clinical significance of cathepsin D in breast cancer metastasis. Stem Cells 14, 642–650 (1995).
    Article Google Scholar
  23. Alfano, R.R. et al. Time-resolved and nonlinear optical imaging for medical applications. Ann. NY. Acad. Sci. 838, 14– 28 (1998).
    Article CAS Google Scholar
  24. Alfano, R., Demos, S. & SK, G. Advances in optical imaging of biomedical media. Ann. NY Acad. Sci. 820, 248–270 ( 1997).
    Article CAS Google Scholar
  25. Benaron, D.A., Cheong, W.F. & Stevenson, D.K. Tissue optics. Science 276, 2002–2003 (1997).
    Article CAS Google Scholar
  26. Hebden, J., Arridge, S. & Delpy, D. Optical imaging in medicine: I. experimental techniques. Phys. Med. Biol. 42, 825– 840 (1997).
    Article CAS Google Scholar
  27. Hebden, J.C. & Delpy, D.T. Diagnostic imaging with light. Br. J. Radiol. 70, S206–S214 (1997).
    Article Google Scholar
  28. Benaron, D.A., Contag, P.R. & Contag, C.H. Imaging brain structure and function, infection and gene expression in the body using light. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 352, 755–761 (1997).
    Article CAS Google Scholar
  29. Villringer, A. Functional neuroimaging. Optical approaches. Adv. Exp. Med. Biol. 413, 1–18 ( 1997).
    Article CAS Google Scholar
  30. Andersson-Engels, S., Klinteberg, C., Svanberg, K. & Svanberg, S. In vivo fluorescence imaging for tissue diagnostics. Phys. Med. Biol. 42, 815–824 ( 1997).
    Article CAS Google Scholar
  31. Manoharan, R. et al. Raman spectroscopy and fluorescence photon migration for breast cancer diagnosis and imaging. Photochem. Photobiol 67, 15–22 (1998).
    Article CAS Google Scholar
  32. Wu, J., Perelman, L., Dasari, R. & Feld, M. Fluorescence tomographic imaging in turbid media using early-arriving photons and Laplace transforms. Proc. Natl. Acad. Sci. USA 94, 8783– 8788 (1997).
    Article CAS Google Scholar
  33. Yavelow, J., Finlay, T.H., Kennedy, A.R. & Troll, W. Bowman-Birk soybean protease inhibitor as an anticarcinogen. Cancer Res. 43, 2454s–2459s ( 1983).
    CAS PubMed Google Scholar
  34. Yu, A.E., Hewitt, R.E., Connor, E.W. & Stetler-Stevenson, W.G. Matrix metalloproteinases. Novel targets for directed cancer therapy. Drugs & Aging 11, 229–244 (1997).
    Article CAS Google Scholar
  35. Wojtowicz-Praga, S.M., Dickson, R.B. & Hawkins, M.J. Matrix metalloproteinase inhibitors. Invest. New Drugs 15, 61–75 ( 1997).
    Article CAS Google Scholar
  36. Tamura, Y. et al. Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives. J. Med. Chem. 41, 640–649 (1998).
    Article CAS Google Scholar
  37. Kennedy, A.R. Cancer prevention by protease inhibitors. Prev. Med. 22, 796–811 (1993).
    Article CAS Google Scholar
  38. Giavazzi, R. et al. Batimastat, a synthetic inhibitor of matrix metalloproteinases, potentiates the antitumor activity of cisplatin in ovarian carcinoma xenografts. Clinical Cancer Research 4, 985–992 (1998).
    CAS PubMed Google Scholar
  39. Denis, L.J. & Verweij, J. Matrix metalloproteinase inhibitors: present achievements and future prospects. Invest. New Drugs 15, 175–185 (1997).
    Article CAS Google Scholar
  40. Bogdanov, A.A. Jr., Martin, C., Bogdanova, A.V., Brady, T.J. & Weissleder, R. An adduct of cis-diamminedichloroplatinum(II) and poly(ethylene glycol)poly(L-lysine)-succinate: synthesis and cytotoxic properties. Bioconj. Chem. 7, 144–149 (1996).
    Article CAS Google Scholar
  41. Weissleder, R., Cheng, H., Marecos, E., Kwong, K. & Bogdanov, A. Non-invasive in vivo mapping of tumor vascular and interstitial volume fractions. Eur. J. Cancer 34, 1448 –1454 (1998).
    Article CAS Google Scholar
  42. Mitch, W. & Goldberg, A. Mechanism of muscle wasting. N. Engl. J. Med. 335, 1897–1905 (1996).
    Article CAS Google Scholar
  43. Tsurugi, K. & Ogata, K. Presence of a thiol protease in regenerating rat-liver nuclei. Partial purification and some properties. Eur. J. Biochem. 109, 9–15 ( 1980).
    Article CAS Google Scholar
  44. Hashida, S., Towatari, T., Kominami, E. & Katunuma, N. Inhibitions by E-64 derivatives of rat liver cathepsin B and cathepsin L in vitro and in vivo. J. Biochem. (Tokyo) 88, 1805–1811 (1980).
    Article CAS Google Scholar
  45. Barrett, A.J., Kembhavi, A.A. & Hanada, K. E-64 [L-trans-epoxysuccinyl-leucyl-amido(4-guanidino)butane] and related epoxides as inhibitors of cysteine proteinases. Acta Biol Med Ger 40, 1513–1517 (1981).
    CAS PubMed Google Scholar
  46. Shau, H. & Dawson, J.R. Regulation of human natural killing by lysosomotropic and thiol- reactive agents. Immunology 55, 647–654 (1985).
    CAS PubMed PubMed Central Google Scholar
  47. Harper, J.W., Hemmi, K. & Powers, J.C. Reaction of serine proteases with substituted isocoumarins: discovery of 3,4-dichloroisocoumarin, a new general mechanism based serine protease inhibitor. Biochemistry 24, 1831 –1841 (1985).
    Article CAS Google Scholar
  48. Hudig, D., Allison, N.J., Kam, C.M. & Powers, J.C. Selective isocoumarin serine protease inhibitors block RNK-16 lymphocyte granule-mediated cytolysis. Mol. Immunol. 26, 793– 798 (1989).
    Article CAS Google Scholar
  49. Powers, J.C. et al. Mechanism-based isocoumarin inhibitors for serine proteases: use of active site structure and substrate specificity in inhibitor design. J. Cell Biochem. 39, 33–46 (1989).
    Article CAS Google Scholar
  50. Tearney, G. et al. In vivo endoscopic optical biopsy with optical coherence tomography. Science 276, 2037–2039 (1997).
    Article CAS Google Scholar
  51. el-Shirbiny, A.M. Prostatic specific antigen. Adv. Clin. Chem. 31, 99–133 (1994).
    Article CAS Google Scholar
  52. Himelstein, B.P., Canete-Soler, R., Bernhard, E.J., Dilks, D.W. & Muschel, R.J. Metalloproteinases in tumor progression: the contribution of MMP-9. Invasion Metastasis 14, 246–258 (1994).
    CAS PubMed Google Scholar
  53. Rha, S.Y. et al. Different expression patterns of MMP-2 and MMP-9 in breast cancer. Oncology Reports 5, 875–879 (1998).
    CAS PubMed Google Scholar
  54. Berquin, I.M. & Sloane, B.F. Cathepsin B expression in human tumors. Adv. Exp. Med. Biol. 389, 281– 294 (1996).
    Article CAS Google Scholar
  55. Bogdanov, A., Weissleder, R. & Brady, T. Long-circulating blood pool imaging agents. Advanced Drug Delivery Reviews 16, 335– 348 (1995).
    Article CAS Google Scholar

Download references